Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic abnormalities in myelodysplastic syndromes.

T Hamblin1

  • 1Department of Immunohaematology, Southampton University, United Kingdom.

Hematology/Oncology Clinics of North America
|June 1, 1992
PubMed
Summary

Myelodysplastic syndromes (MDS) are linked to autoimmune issues and abnormal lymphocytes. Research suggests the lymphoid system plays a role in the MDS disease process.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autumn Books: The paranormal defended.

British medical journal (Clinical research ed.)·2010
Same author

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.

Lancet (London, England)·2007
Same author

Disturbances in peripheral blood B cell subpopulations in autoimmune patients.

Lupus·2003
Same author

Chronic lymphocytic leukaemia: one disease or two?

Annals of hematology·2002
Same author

Historical aspects of chronic lymphocytic leukaemia.

British journal of haematology·2001
Same author

Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Myelodysplastic syndromes (MDS) exhibit frequent autoimmune phenomena.
  • Abnormalities in lymphocyte subsets (number and function) are observed in MDS patients.
  • Lymphoid malignancies and lymphoblastic evolution are occasionally reported in MDS.

Purpose of the Study:

  • To investigate the connection between autoimmune phenomena and lymphoid system abnormalities in myelodysplastic syndromes.
  • To explore the potential role of the lymphoid system in the pathogenesis of MDS.

Main Methods:

  • Analysis of lymphocyte subsets in MDS patients.
  • Review of associated lymphoid malignancies and lymphoblastic evolution.
  • Molecular studies to assess lymphoid system involvement.

Main Results:

  • Autoimmune phenomena are more common than expected in MDS.
  • Lymphocyte subsets show abnormalities in number and function.
  • Evidence suggests lymphoid system involvement in the dysplastic process of MDS.

Conclusions:

  • The lymphoid system is implicated in the pathogenesis of myelodysplastic syndromes.
  • Understanding this connection may lead to new therapeutic strategies for MDS.

Related Experiment Videos